ClinConnect ClinConnect Logo
Search / Trial NCT02164136

Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients

Launched by THIRD AFFILIATED HOSPITAL, SUN YAT-SEN UNIVERSITY · Jun 12, 2014

Trial Information

Current as of June 27, 2025

Unknown status

Keywords

ClinConnect Summary

No description provided

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Age from over 20 to under 60 years;
  • Primary rectal adenocarcinoma confirmed pathologically by endoscopic biopsy;
  • Mid-low rectal cancer (distance from anal edge≤12cm);
  • cT1-3, N0-3, M0 at preoperative evaluation according to the AJCC Cancer Staging Manual Seventh Edition;
  • Expected curative resection through both L-PANP-TME and O-PANP-TME;
  • Performance status of 0 or 1 on ECOG (Eastern Cooperative Oncology Group) scale;
  • ASA (American Society of Anesthesiology) score class I, II, or III;
  • Written informed consent;
  • Urinary and sexual function normal preoperatively
  • Exclusion Criteria:
  • Women during pregnancy or breast-feeding;
  • Severe mental disorder;
  • History of previous pelvic surgery;
  • Enlarged or bulky regional lymph node diameter over 3cm by preoperative imaging;
  • History of other malignant disease within past five years;
  • History of unstable angina or myocardial infarction within past six months;
  • History of cerebrovascular accident within past six months;
  • History of continuous systematic administration of corticosteroids within one month;
  • Contraindication of heart, brain, lung, etc dysfunction;
  • Requirement of simultaneous surgery for other disease;
  • Emergency surgery due to complication (bleeding, obstruction or perforation) caused by rectal cancer;
  • Rectal cancer invades surrounding tissues;
  • Existence of genuine incontinence or severe stress incontinence preoperatively

About Third Affiliated Hospital, Sun Yat Sen University

The Third Affiliated Hospital of Sun Yat-sen University is a leading medical institution in China, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its comprehensive resources and multidisciplinary expertise to facilitate cutting-edge studies that aim to improve patient outcomes and contribute to the global body of medical knowledge. With a focus on collaboration and patient-centered care, the Third Affiliated Hospital is dedicated to fostering advancements in medical science and ensuring the highest standards of ethical practice in clinical research.

Locations

Guangzhou, Guangdong, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials